AVX
Click for more information
0.00% 2.5¢ avexa limited

aus fin review

  1. cortinaboy
    1,203 Posts.
    lightbulb Created with Sketch. 66
    clock Created with Sketch.
    16/03/07
    07:56
    Post #: 2274193
    All looks good for Monday with a great article in this morning's Fin Review that says the Phase IIb trial of its apricitabine (ATC) drug has produced a better than hoped for results. Also speculates that Avexa will announce a capital raising of about $25 million. The journalist says that Avexa could be sitting on a pharmaceutical goldmine.
    AVX Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AVX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.